Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LAB NASDAQ:MASS NASDAQ:PRE NASDAQ:RPID On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$0.89-2.1%$0.98$0.79▼$1.72$354.02M1.393.69 million shs1.75 million shsMASS908 Devices$8.27+0.6%$7.48$5.03▼$9.34$310.83M0.63252,787 shs172,331 shsPREPrenetics Global$21.63+4.5%$18.24$6.88▼$23.63$349.12M0.24296,672 shs348,508 shsRPIDRapid Micro Biosystems$1.76-6.4%$2.18$1.76▼$4.94$86.80M1.45149,672 shs144,718 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools+2.93%-28.59%-10.21%-2.76%-16.03%MASS908 Devices+2.62%-6.80%+7.45%+35.42%+12.91%PREPrenetics Global+7.48%-0.48%+15.01%-0.14%+172.24%RPIDRapid Micro Biosystems+2.73%-5.53%-27.13%-33.57%-50.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$0.89-2.1%$0.98$0.79▼$1.72$354.02M1.393.69 million shs1.75 million shsMASS908 Devices$8.27+0.6%$7.48$5.03▼$9.34$310.83M0.63252,787 shs172,331 shsPREPrenetics Global$21.63+4.5%$18.24$6.88▼$23.63$349.12M0.24296,672 shs348,508 shsRPIDRapid Micro Biosystems$1.76-6.4%$2.18$1.76▼$4.94$86.80M1.45149,672 shs144,718 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools+2.93%-28.59%-10.21%-2.76%-16.03%MASS908 Devices+2.62%-6.80%+7.45%+35.42%+12.91%PREPrenetics Global+7.48%-0.48%+15.01%-0.14%+172.24%RPIDRapid Micro Biosystems+2.73%-5.53%-27.13%-33.57%-50.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABStandard BioTools 1.67Reduce$1.3552.08% UpsideMASS908 Devices 2.00Hold$12.0045.10% UpsidePREPrenetics Global 2.50Moderate Buy$32.3349.48% UpsideRPIDRapid Micro Biosystems 2.33Hold$6.00240.91% UpsideCurrent Analyst Ratings BreakdownLatest RPID, PRE, LAB, and MASS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2026RPIDRapid Micro Biosystems KeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$8.00 ➝ $5.005/27/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)5/22/2026RPIDRapid Micro Biosystems Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$8.00 ➝ $7.005/11/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Sell (D+)5/11/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D-)4/24/2026LABStandard BioTools Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026PREPrenetics Global Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026RPIDRapid Micro Biosystems Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/13/2026MASS908 Devices Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D+) ➝ Hold (C-)3/16/2026PREPrenetics Global Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$29.00(Data available from 6/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABStandard BioTools$85.33M4.06N/AN/A$1.10 per share0.81MASS908 Devices$56.20M5.56N/AN/A$3.97 per share2.08PREPrenetics Global$92.39M3.95N/AN/A$9.27 per share2.33RPIDRapid Micro Biosystems$33.59M2.42N/AN/A$0.75 per share2.35Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABStandard BioTools-$74.90M$0.20N/AN/AN/A73.46%-8.18%-6.43%8/10/2026 (Estimated)MASS908 Devices$19.49M-$1.00N/AN/AN/A-62.40%-14.03%-10.40%8/4/2026 (Estimated)PREPrenetics Global-$37.71M-$4.58N/A49.16N/A-62.45%-20.33%-15.42%N/ARPIDRapid Micro Biosystems-$47.12M-$1.12N/AN/AN/A-145.81%-131.52%-67.48%7/31/2026 (Estimated)Latest RPID, PRE, LAB, and MASS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026RPIDRapid Micro Biosystems-$0.25-$0.31-$0.06-$0.31$7.60 million$8.00 million3/12/2026Q4 2025RPIDRapid Micro Biosystems-$0.23-$0.28-$0.05-$0.28$10.93 million$11.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLABStandard BioToolsN/AN/AN/AN/AN/AMASS908 DevicesN/AN/AN/AN/AN/APREPrenetics Global$2.8012.79%N/AN/A N/ARPIDRapid Micro BiosystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABStandard BioToolsN/A12.3611.92MASS908 DevicesN/A3.583.25PREPrenetics GlobalN/A5.152.72RPIDRapid Micro Biosystems0.932.571.66Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABStandard BioTools53.74%MASS908 Devices88.06%PREPrenetics Global25.01%RPIDRapid Micro Biosystems52.60%Insider OwnershipCompanyInsider OwnershipLABStandard BioTools26.81%MASS908 Devices28.20%PREPrenetics Global7.80%RPIDRapid Micro Biosystems12.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABStandard BioTools620390.37 million285.71 millionOptionableMASS908 Devices6037.81 million27.15 millionOptionablePREPrenetics Global116.87 million15.56 millionNot OptionableRPIDRapid Micro Biosystems20046.17 million40.31 millionNot OptionableRPID, PRE, LAB, and MASS HeadlinesRecent News About These CompaniesRapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 10 at 4:50 PM | markets.businessinsider.comRapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)June 10 at 4:30 PM | globenewswire.comRapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potentialMay 19, 2026 | msn.comRapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and WarrantsMay 18, 2026 | quiverquant.comQRapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten OfferingMay 18, 2026 | globenewswire.comRapid Micro Biosystems Earnings Call Balances Growth And RiskMay 16, 2026 | theglobeandmail.comRapid Micro Biosystems Q1 2026 Earnings Call: Complete TranscriptMay 14, 2026 | finance.yahoo.comRapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...May 14, 2026 | finance.yahoo.comRapid Micro Biosystems Q1 Earnings Call HighlightsMay 13, 2026 | marketbeat.comRapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call TranscriptMay 13, 2026 | seekingalpha.comRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesMay 13, 2026 | zacks.comRapid Micro Biosystems Reports First Quarter 2026 Revenue of $8.0 Million with 11% Year-Over-Year GrowthMay 13, 2026 | quiverquant.comQRapid Micro Biosystems Reports First Quarter 2026 Financial ResultsMay 13, 2026 | globenewswire.comRapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026May 6, 2026 | globenewswire.comWhite Brook Capital Shared Insights on Rapid Micro Biosystems (RPID)April 23, 2026 | insidermonkey.comWhat Makes Rapid Micro Biosystems (RPID) a New Buy StockApril 14, 2026 | zacks.comRapid Micro Biosystems Faces ESG-Related Reputational and Operational Risks Amid Evolving Sustainability RulesMarch 14, 2026 | tipranks.comInsider Selling: Rapid Micro Biosystems (NASDAQ:RPID) CFO Sells 7,480 Shares of StockMarch 13, 2026 | insidertrades.comRapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Report Preview: What To Look ForMarch 13, 2026 | finance.yahoo.comRapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2025 earnings call transcriptMarch 13, 2026 | msn.comRapid Micro Biosystems: Big Pharma Adoption Driving GrowthMarch 13, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWill the SpaceX IPO Put These 5 Public Space Stocks Into a Higher Orbit?By Ryan Hasson | June 2, 20263 Stocks to Own If Gas Prices Keep RisingBy Dan Schmidt | May 16, 2026Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?By Ryan Hasson | June 4, 2026Micron’s $1 Trillion Memory Melt-UpBy Jeffrey Neal Johnson | May 27, 2026Rocket Lab Keeps Making Headlines and Highs—Here's What's Driving the Latest MoveBy Ryan Hasson | May 27, 2026RPID, PRE, LAB, and MASS Company DescriptionsStandard BioTools NASDAQ:LAB$0.89 -0.02 (-2.12%) Closing price 04:00 PM EasternExtended Trading$0.88 -0.01 (-1.43%) As of 06:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.908 Devices NASDAQ:MASS$8.27 +0.05 (+0.61%) Closing price 04:00 PM EasternExtended Trading$8.28 +0.01 (+0.12%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.Prenetics Global NASDAQ:PRE$21.63 +0.94 (+4.54%) Closing price 04:00 PM EasternExtended Trading$21.33 -0.30 (-1.38%) As of 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Rapid Micro Biosystems NASDAQ:RPID$1.76 -0.12 (-6.38%) Closing price 04:00 PM EasternExtended Trading$1.78 +0.01 (+0.85%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears DraftKings Hits the Jackpot With Super App Pivot Cracker Barrel Surges 23% as Earnings Beat Signals Turnaround Progress Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
